Skip to main content
. Author manuscript; available in PMC: 2007 Jul 23.
Published in final edited form as: Pediatr Transplant. 2007 May;11(3):312–318. doi: 10.1111/j.1399-3046.2006.00626.x

Table III.

Safety Data. NCI Grading Score for Each Distinct Time Period One Year After Pediatric Lung Transplantation.

NCI Grading*
Time period of Ganciclovir given: 0–I II–III IV
Transplant to 12 weeks:
 Neutropenia 8/9 1/9 0
 Anemia (Hemoglobin) 4/9 5/9 0
 Thrombocytopenia 9/9 0 0
 Creatinine 3/9 6/9 0
12 weeks to IV Ganciclovir discontinued (patient specific):
 Neutropenia 8/9 1/9 0
 Anemia (Hemoglobin) 6/9 3/9 0
 Thrombocytopenia 9/9 0 0
 Creatinine 4/9 5/9 0
Time from IV Ganciclovir therapy discontinuation to study completion:
 Neutropenia 8/9 1/9 0
 Anemia (Hemoglobin) 7/9 2/9 0
 Thrombocytopenia 9/9 0 0
 Creatinine 2/9 6/9 1/9
*NCI Grading
Adverse Event 0 I II III IV
Neutropenia WNL ≥1500–<2000/mm3 ≥1000–<1500/mm3 ≥500–<1000/mm3 <500/mm3
Anemia (Hb) WNL LLN- 10 g/dL 8–10 g/dL 6.5–8 g/dL <6.5 g/dL
Thrombocytopenia WNL <LLN -75,000/mm3 ≥50,000–<75,000/mm3 ≥10,000–<50,000/mm3 <10,000mm3
Creatinine WNL >ULN-1.5 × ULN ≥ 1.5–3 × ULN ≥ 3–6 × ULN ≥ 6 × ULN